INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble
Go back to INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble| (NASDAQ: INMB) | Delayed: 2.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $ | |||
| Open | $2.51 | 52 Week Low | $ | |||
| Day High | $2.51 | P/E | N/A | |||
| Day Low | $2.51 | EPS | $ | |||
| Volume | 1,109 | |||||
